GSO ISO 23958-2:2024

ISO 23958-2:2022
Gulf Standard   Current Edition · Approved on 14 October 2024

Traditional Chinese medicine — Dermal needles for single use — Part 2: Roller-type

GSO ISO 23958-2:2024 Files

GSO ISO 23958-2:2024 Scope

This document specifies the particular requirements for the basic safety and essential performance of roller-type dermal needles for single use. It applies to roller-type dermal needles that have the capacity to penetrate the skin.

It specifies structure and dimension, materials, and performance requirements for appearance and cleanliness, corrosion resistance, sterility, packaging and identification, transit and storage of roller-type dermal needles.

It does not apply to tapping-type dermal needles or reusable roller-type dermal needles.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 2063:2023
 
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants

Recently Published from Health Sector

GSO ISO 20776-2:2024
ISO 20776-2:2021 
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution
GSO ISO 27186:2024
ISO 27186:2020 
Gulf Standard
Active implantable medical devices — Four-pole connector system for implantable cardiac rhythm management devices — Dimensional and test requirements
GSO ISO 28620:2024
ISO 28620:2020 
Gulf Standard
Medical devices — Non-electrically driven portable infusion devices
GSO ISO 20776-1:2024
ISO 20776-1:2019 
Gulf Standard
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases